share_log

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

聽說 Vistagen Therapeutics 在傑富瑞集團從持倉升級爲買入;目標股價爲15美元
Benzinga ·  2023/12/06 19:10

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

聽說 Vistagen Therapeutics 在傑富瑞集團從持倉升級爲買入;目標股價爲15美元

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論